Invesco’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
66,750
+11,438
| +21% | +$183K | ﹤0.01% | 2817 |
|
|
2025
Q1 | $945K | Sell |
55,312
-448,720
| -89% | -$7.67M | ﹤0.01% | 2846 |
|
|
2024
Q4 | $12.5M | Sell |
504,032
-90,210
| -15% | -$2.23M | ﹤0.01% | 1716 |
|
|
2024
Q3 | $16.9M | Buy |
594,242
+23,344
| +4% | +$666K | ﹤0.01% | 1550 |
|
|
2024
Q2 | $15.1M | Buy |
570,898
+44,665
| +8% | +$1.18M | ﹤0.01% | 1568 |
|
|
2024
Q1 | $17M | Buy |
526,233
+34,118
| +7% | +$1.1M | ﹤0.01% | 1530 |
|
|
2023
Q4 | $20.7M | Buy |
492,115
+253,060
| +106% | +$10.7M | ﹤0.01% | 1387 |
|
|
2023
Q3 | $9.18M | Buy |
239,055
+216,455
| +958% | +$8.31M | ﹤0.01% | 1817 |
|
|
2023
Q2 | $429K | Buy |
22,600
+6,563
| +41% | +$125K | ﹤0.01% | 3311 |
|
|
2023
Q1 | $249K | Sell |
16,037
-825
| -5% | -$12.8K | ﹤0.01% | 3537 |
|
|
2022
Q4 | $299K | Buy |
16,862
+828
| +5% | +$14.7K | ﹤0.01% | 3488 |
|
|
2022
Q3 | $89K | Sell |
16,034
-209
| -1% | -$1.16K | ﹤0.01% | 3831 |
|
|
2022
Q2 | $63K | Sell |
16,243
-2,457
| -13% | -$9.53K | ﹤0.01% | 3918 |
|
|
2022
Q1 | $103K | Buy |
18,700
+711
| +4% | +$3.92K | ﹤0.01% | 3828 |
|
|
2021
Q4 | $153K | Sell |
17,989
-2,935
| -14% | -$25K | ﹤0.01% | 3801 |
|
|
2021
Q3 | $182K | Sell |
20,924
-841,089
| -98% | -$7.32M | ﹤0.01% | 3800 |
|
|
2021
Q2 | $9.11M | Buy |
862,013
+2,151
| +0.3% | +$22.7K | ﹤0.01% | 2105 |
|
|
2021
Q1 | $13.8M | Sell |
859,862
-267,625
| -24% | -$4.29M | ﹤0.01% | 1762 |
|
|
2020
Q4 | $52.1M | Buy |
1,127,487
+882,862
| +361% | +$40.8M | 0.02% | 1007 |
|
|
2020
Q3 | $8.61M | Buy |
244,625
+94,776
| +63% | +$3.34M | ﹤0.01% | 1725 |
|
|
2020
Q2 | $3.65M | Buy |
+149,849
| New | +$3.65M | ﹤0.01% | 2163 |
|